The age at which someone is tested for von Willebrand disease (VWD) significantly affects their diagnosis, according to new analysis led by Irish researchers.
The findings could be important in addressing the challenges in the misdiagnosis and tre...
1 year ago
Offering prophylactic treatment before immunotherapy could significantly reduce the rate of cytokine release syndrome in multiple myeloma patients, a new US study has found.
Treatment breakthroughs, such as the immunotherapy drug teclistamab, can...
1 year ago
